Graves' orbitopathy: What’s new? Case report with diagnostic and therapeutic update
1 Department of Endocrinology, Oued Eddahab Military Hospital, Agadir Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech, Morocco.
2 Department of Ophthalmology, Oued Eddahab Military Hospital, Agadir Faculty of Medicine and Pharmacy, Ibn Zohr University, Agadir, Morocco.
3 Department of stomatology and maxillofacial surgery, Oued Eddahab Military Hospital, Agadir.
4 Department of pharmacy, Oued Eddahab Military Hospital, Agadir, Morocco.
5 Department of surgery, Oued Eddahab Military Hospital, Agadir Faculty of Medicine and Pharmacy, Ibn Zohr University, Agadir, Morocco.
Case Study
World Journal of Advanced Research and Reviews, 2024, 21(02), 313–319
Publication history:
Received on 26 December 2023; revised on 03 February 2024; accepted on 05 February 2024
Abstract:
Orbitopathy is the most common extra-thyroidal complication of Graves' disease and is a potentially serious pathology as it threatens the functional prognosis. Its management is complex and requires a multidisciplinary approach. We report the case of a 26-year-old female patient followed for 2 years for Graves' disease with a very severe Graves’ Orbitopathy (GO) requiring close monitoring and multidisciplinary collaboration to preserve the visual prognosis. Our article illustrates the seriousness of this pathology and provides an update on the latest diagnostic and therapeutic modalities.
Keywords:
Graves' orbitopathy; Graves' disease; Medical treatment; Orbital decompression; Multidisciplinary management
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0